U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219654) titled 'Efficacy and Safety Study of TPX-115 on Partial-thickness Rotator Cuff Tear' on Oct. 20.
Brief Summary: The goal of this study is to evaluate the efficacy and safety of allogeneic dermal fibroblasts (TPX-115) compared to placebo in patients with Partial-Thickness Rotator Cuff Tear(PTRCT).
Primary endpoint is to evaluate the efficacy of TPX-115 compared to placebo, as measured by improvement in the Constant-Murley Score (CMS) in patients with PTRCT.
Secondary endpoints are:
* To evaluate functional (including shoulder pain) and structural improvements in the affected shoulder after administration of TPX-115 compared to placebo in ...